Greiner Bio-One Displays Range of Safety Products at MedLab
|
By LabMedica International staff writers Posted on 31 Jan 2019 |

Image: The VACUETTE range of safety products (Photo courtesy of Greiner Bio-One).
Greiner Bio-One (Kremsmünster, Austria) exhibited its wide range of VACUETTE safety products at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. MedLab is the flagship exhibition and congress of the MedLab Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning across the Middle East, Asia, East/West Africa, Europe and the US. The Medlab Series covers all disciplines in the laboratory department and provides a unique platform for the industry’s multi-level professionals to meet under one roof.
Needlestick injuries from contaminated puncture devices are the most common source of infection for diseases transmitted by blood or other bodily fluids and are still among the most common occupational accidents today. Greiner Bio-One Preanalytics has been developing a range of safety products to reduce the risk of contamination and needlestick injuries, providing protection against potential injury risks.
At MedLab Middle East 2019, Greiner Bio-One exhibited its VACUETTE safety blood collection sets, which are particularly suitable for blood collection from patients with difficult veins. An integrated safety mechanism that is already activated in the patient's vein provides even greater safety in the blood collection process. The VACUETTE safety blood collection sets are available in different needle sizes and tubing lengths.
Greiner Bio-One also displayed its VACUETTE QUICKSHIELD safety tube holder, which enables greater flexibility related to user and patient-specific requirements due to its rotating safety shield. Additionally, the holder’s ergonomic design provides the user with a better grip for puncturing. The safety shield can be activated either one-handed with the aid of a solid surface or simply with the thumb.
Needlestick injuries from contaminated puncture devices are the most common source of infection for diseases transmitted by blood or other bodily fluids and are still among the most common occupational accidents today. Greiner Bio-One Preanalytics has been developing a range of safety products to reduce the risk of contamination and needlestick injuries, providing protection against potential injury risks.
At MedLab Middle East 2019, Greiner Bio-One exhibited its VACUETTE safety blood collection sets, which are particularly suitable for blood collection from patients with difficult veins. An integrated safety mechanism that is already activated in the patient's vein provides even greater safety in the blood collection process. The VACUETTE safety blood collection sets are available in different needle sizes and tubing lengths.
Greiner Bio-One also displayed its VACUETTE QUICKSHIELD safety tube holder, which enables greater flexibility related to user and patient-specific requirements due to its rotating safety shield. Additionally, the holder’s ergonomic design provides the user with a better grip for puncturing. The safety shield can be activated either one-handed with the aid of a solid surface or simply with the thumb.
Latest MEDLAB 2019 News
- ERBA Group Launches New Hematology Analyzers at MEDLAB 2019
- Telstar Promotes Latest Generation of Freeze Dryers in Dubai
- Siemens Healthineers Showcases In-Vitro Diagnostics Products at MedLab 2019
- Randox Promotes Evidence MultiSTAT Automated Benchtop Immunoassay Analyzer
- Mindray Displays New Generation Benchtop Cellular Analysis Line
- HORIBA Medical Shows Latest Yumizen G Range at Lab Trade Show
- EKF Diagnostics Presents Latest Diabetes Care Analyzers
- BioSystems Highlights New iFOB Integral System at MedLab 2019
- Beckman Coulter Exhibits New Hematology Analyzer in Middle East
- Agappe Diagnostics Displays Analyzers and Solutions at Middle East Congress
- Abbott Highlights Point of Care Management Solutions
Channels
Clinical Chemistry
view channel
Compact Raman Imaging System Detects Subtle Tumor Signals
Accurate cancer diagnosis often depends on labor-intensive tissue staining and expert pathological review, which can delay results and limit access to rapid screening. These conventional methods also make... Read more
Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
People with diabetes often need to measure their blood glucose multiple times a day, most commonly through finger-prick blood tests or implanted sensors. These methods can be painful, inconvenient, and... Read moreMolecular Diagnostics
view channel
Neuron-Derived Extracellular Vesicles Could Improve Alzheimer’s Diagnosis
Alzheimer’s disease is becoming increasingly common as global populations age, yet effective treatments for advanced stages remain limited. Early detection is therefore critical, but current diagnostic... Read more
Sample Prep Instrument to Empower Decentralized PCR Testing for Tuberculosis
Tuberculosis remains the deadliest infectious disease worldwide despite being both treatable and curable when diagnosed early. A major barrier to timely diagnosis is that PCR-based TB testing is still... Read more
Endometriosis Blood Test Could Replace Invasive Laparoscopic Diagnosis
Endometriosis affects an estimated 1 in 10 women globally, yet diagnosis can take 7 to 10 years on average due to the invasive nature of laparoscopy and lack of accurate, non-invasive tests.... Read more
World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device
Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read moreHematology
view channel
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs
Colon cancer remains a major cause of cancer-related illness, with many patients facing relapse even after surgery and chemotherapy. Up to 40% of people with stage III disease experience recurrence, highlighting... Read moreMicrobiology
view channel
New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
Urinary tract infections affect around 152 million people every year, making them one of the most common bacterial infections worldwide. In routine medical practice, diagnosis often relies on rapid urine... Read more
Breakthroughs in Microbial Analysis to Enhance Disease Prediction
Microorganisms shape human health, ecosystems, and the planet’s climate, yet identifying them and understanding how they are related remains a major scientific challenge. Even with modern DNA sequencing,... Read morePathology
view channel
AI Tool Simultaneously Identifies Genetic Mutations and Disease Type
Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups
Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Tumor Signals in Saliva and Blood Enable Non-Invasive Monitoring of Head and Neck Cancer
Head and neck cancers are among the most aggressive malignancies worldwide, with nearly 900,000 new cases diagnosed each year. Monitoring these cancers for recurrence or relapse typically relies on tissue... Read moreTechnology
view channel
AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
Colorectal cancer is one of the most common and deadly cancers worldwide, and accurately predicting patient survival remains a major clinical challenge. Traditional prognostic tools often rely on either... Read more
Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
Glioblastoma is one of the most aggressive and fatal brain cancers, with most patients surviving less than two years after diagnosis. Treatment is particularly challenging because the tumor infiltrates... Read moreIndustry
view channel
BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) has entered into a strategic collaboration with the Institute for Immunology and Immune Health (I3H, Philadelphia, PA, USA) at the University... Read more








